DNA Repair Enzymes as Promising Targets in Oncotherapy
Authors:
- 1 January 2018
- journal article
- review article
- Published by Pleiades Publishing Ltd in Russian Journal of Bioorganic Chemistry
- Vol. 44 (1) , 1-18
Abstract
DNA repair is a complicated process that occurs due to a network of different pathways and mechanisms for correction of DNA damages during the normal DNA biosynthesis and under the influence of...Keywords
This publication has 148 references indexed in Scilit:
- Synthesis and Biological Evaluation of the First Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)–Topoisomerase I (Top1) InhibitorsJournal of Medicinal Chemistry, 2012
- The role of PARP in DNA repair and its therapeutic exploitationBritish Journal of Cancer, 2011
- The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrestDNA Repair, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The PARP Side of the Nucleus: Molecular Actions, Physiological Outcomes, and Clinical TargetsMolecular Cell, 2010
- 4-Pregnen-21-ol-3,20-dione-21-(4-bromobenzenesufonate) (NSC 88915) and Related Novel Steroid Derivatives as Tyrosyl-DNA Phosphodiesterase (Tdp1) InhibitorsJournal of Medicinal Chemistry, 2009
- Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxinDNA Repair, 2009
- Tdp1 protects against oxidative DNA damage in non‐dividing fission yeastThe EMBO Journal, 2009
- DNA Polymerases as Therapeutic TargetsBiochemistry, 2008
- XRCC1 and DNA polymerase β in cellular protection against cytotoxic DNA single-strand breaksCell Research, 2008